Stockreport

Climb Bio taps Susan Altschuller as CFO [Seeking Alpha]

Climb Bio, Inc.  (CLYM) 
PDF She served as the chief financial officer of Cerevel Therapeutics, until its $8.7B acquisition by AbbVie, and as chief financial officer of ImmunoGen. More on Climb Bi [Read more]